Effect of Cupping Therapy on Nitric Oxide Level in Patients With Cervical Spondylosis
CT
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
this study will be conducted to investigate the effect of cupping therapy on the nitric oxide level in patients with cervical spondylosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2024
CompletedStudy Start
First participant enrolled
February 20, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2024
CompletedFebruary 21, 2024
February 1, 2024
3 months
February 14, 2024
February 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the nitric oxide level
Spectrophotometer device will be used to measure the level of nitric oxide
up to three months
Secondary Outcomes (2)
cervical range of motion
up to three months
pain intensity
up to three months
Study Arms (1)
cupping therapy
EXPERIMENTALpatients with cervical spondylosis will receive cupping therapy one time per month for three months
Interventions
All the patients will be asked to be in a sitting position with both feet flat on the floor the cupping group will receive the cupping bloodletting at three acupuncture points (SI15, GB21, LI15) the medium size glass with a diameter of 4cm and a volume of 260ml. Each wet cupping treatment procedure will last about 20 min and will be conducted in five steps. 1. -Primary sucking 2. -Scarification 3- Bloodletting 4-Removal 5 -Dressing
Eligibility Criteria
You may qualify if:
- Patients with (cervical spondylosis) from both sexes.
- Age range (24-60) in chronic stages.
- BMI from20-25 kg/m2.
You may not qualify if:
- Renal and hepatic patients.
- Anemia, hepatic disease, and dermatological diseases.
- Morbid obese patients if their BMI exceeds the 25 kg/m2 will be also excluded.
- the patients are taking any medications known to affect the pain level
- The patients have a systemic illness, dermatological problems, skin allergy, local ischemic problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- principle investigator shady abdelsattar refaat
Study Record Dates
First Submitted
February 14, 2024
First Posted
February 21, 2024
Study Start
February 20, 2024
Primary Completion
May 20, 2024
Study Completion
May 20, 2024
Last Updated
February 21, 2024
Record last verified: 2024-02